FMBH(FMBH)
FMBH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $426M | $453M |
| Low | $424M | $450M |
| High | $430M | $456M |
| EBITDA Avg | $131M | $139M |
| Low | $131M | $139M |
| High | $133M | $141M |
| EBIT Avg | $111M | $118M |
| Low | $111M | $117M |
| High | $112M | $119M |
| Net Income Avg | $106M | $119M |
| Low | $104M | $117M |
| High | $107M | $120M |
| EPS Avg | $4.42 | $4.94 |
| Low | $4.32 | $4.89 |
| High | $4.48 | $4.99 |
| Analysts (Rev / EPS) | 5 / 6 | 5 / 6 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $108M | $110M | $112M | $112M | $113M | $115M |
| Low | $108M | $109M | $111M | $111M | $112M | $114M |
| High | $109M | $112M | $113M | $113M | $114M | $116M |
| EBITDA Avg | $33M | $34M | $35M | $35M | $35M | $35M |
| Low | $33M | $33M | $34M | $34M | $35M | $35M |
| High | $33M | $35M | $35M | $35M | $35M | $36M |
| EBIT Avg | $28M | $29M | $29M | $29M | $29M | $30M |
| Low | $28M | $28M | $29M | $29M | $29M | $30M |
| High | $28M | $29M | $29M | $29M | $30M | $30M |
| Net Income Avg | $30M | $32M | $33M | $32M | $33M | $34M |
| Low | $29M | $31M | $33M | $32M | $32M | $33M |
| High | $31M | $33M | $34M | $33M | $33M | $34M |
| EPS Avg | $1.13 | $1.19 | $1.25 | $1.21 | $1.22 | $1.26 |
| Low | $1.10 | $1.16 | $1.23 | $1.20 | $1.21 | $1.25 |
| High | $1.17 | $1.23 | $1.26 | $1.23 | $1.24 | $1.28 |
| Analysts (Rev / EPS) | 4 / 5 | 4 / 5 | 2 / 3 | 2 / 3 | 2 / 3 | 2 / 3 |